{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:48:20Z","timestamp":1785710900138,"version":"3.56.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High resolution 1H nuclear magnetic resonance (NMR) spectroscopic analysis of biofluids is a recently established tool for evaluating inherited and acquired errors in metabolic control. In the present study 1H NMR analysis of urine was used to monitor efficacy of BRL 49653, a potent and selective antihyperglycaemic agent, following oral administration for up to 36 weeks to the genetically diabetic C57BL\/KsJ db\/db mouse. The effects of BRL 49653 on carbohydrate and fatty acid metabolism were monitored by determination of changes in concentrations of low molecular weight urinary metabolites.<\/jats:p><jats:p>A qualitative comparison of the NMR spectra of urine from untreated diabetic mice with those of lean littermates and literature examples revealed several abnormalities, the majority of which could be explained in terms of the non-insulin dependent diabetes syndrome exhibited by these animals. Quantitatively the most prominent was the extreme glycosuria of both young (8\u201312 weeks; 0.9 g glucose kg\u22121 h\u22121) and older (42 weeks; 2 g glucose kg\u22121 h\u22121) diabetic mice. This was accompanied by the excretion of a number of unassigned sugar derivatives and by ketone bodies. Administration of BRL 49653 (3 \u03bcmol kg\u22121) to db\/db mice for 24 days reduced blood glucose concentrations to values comparable with non-diabetic lean littermates and reduced glycosuria by &amp;gt; 90%. BRL 49653 significantly reduced excretion of unassigned sugars, acetate, lactate, and the ketone bodies, acetoacetate, 3-d-hydroxybutyrate and acetone.<\/jats:p><jats:p>The anti-diabetic efficacy of BRL 49653, assessed from the pattern of urinary metabolites, was maintained over a 36-week treatment period. These results demonstrate the value of 1H NMR to evaluate non-invasively the efficacy of novel therapeutic agents.<\/jats:p>","DOI":"10.1111\/j.2042-7158.1997.tb06808.x","type":"journal-article","created":{"date-parts":[[2011,4,13]],"date-time":"2011-04-13T04:44:20Z","timestamp":1302669860000},"page":"336-344","source":"Crossref","is-referenced-by-count":19,"title":["Antidiabetic Efficacy of BRL 49653, a Potent Orally Active Insulin Sensitizing Agent, Assessed in the C57BL\/KsJ<i>db\/db<\/i>Diabetic Mouse by Non-invasive 1H NMR Studies of Urine"],"prefix":"10.1093","volume":"49","author":[{"given":"S C","family":"Connor","sequence":"first","affiliation":[{"name":"SmithKline Beecham Pharmaceuticals, New Frontiers Science Park-North , Third Avenue, Harlow, Essex CM19 SAW,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Hughes","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Pharmaceuticals, New Frontiers Science Park-North , Third Avenue, Harlow, Essex CM19 SAW,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Moore","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Pharmaceuticals, New Frontiers Science Park-North , Third Avenue, Harlow, Essex CM19 SAW,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Lister","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Pharmaceuticals, New Frontiers Science Park-North , Third Avenue, Harlow, Essex CM19 SAW,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Smith","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Pharmaceuticals, New Frontiers Science Park-North , Third Avenue, Harlow, Essex CM19 SAW,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1997,3,1]]},"reference":[{"issue":"Suppl. 1","key":"2024103110233371900_cit1","first-page":"71A","article-title":"BRL 49653 protects against nephropathy in obese Zucker rats: functional evidence","volume":"44","author":"Al-Barazanji","year":"1995","journal-title":"Diabetes"},{"key":"2024103110233371900_cit2","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/jm00049a017","article-title":"[[\u03c9-Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycaemic agents","volume":"37","author":"Cantello","year":"1994","journal-title":"J. Med. Chem."},{"key":"2024103110233371900_cit3","first-page":"255","article-title":"Antihyperglycaemic thiazolidinediones: ciglitazone and its analogues","volume-title":"New Antidiabetic Drugs","author":"Colca","year":"1990"},{"key":"2024103110233371900_cit4","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/ac00151a011","article-title":"Chemical exchange and paramagnetic T2 relaxation agents for water suppression in spin-echo proton NMR spectroscopy of biofluids","volume":"59","author":"Connor","year":"1987","journal-title":"Anal. Chem."},{"key":"2024103110233371900_cit5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"The triumvirate: \u03b2-cell, muscle, liver: a collusion responsible for NIDDM","volume":"37","author":"De Fronzo","year":"1988","journal-title":"Diabetes"},{"key":"2024103110233371900_cit6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(86)90161-0","article-title":"1,6-anhydro-\u03b2-d-glucopyranose (\u03b2-glucosan), a constituent of human urine","volume":"159","author":"Dorland","year":"1986","journal-title":"Linica Chimica Acta"},{"key":"2024103110233371900_cit7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/diab.37.11.1549","article-title":"Characterisation of new oral antidiabetic agent CS-045. Studies in KK and ob\/ob mice and Zucker fatty rats","volume":"37","author":"Fujiwara","year":"1988","journal-title":"Diabetes"},{"key":"2024103110233371900_cit8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0026-895X(25)09200-4","article-title":"Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury (2) chloride and 2-bromoethanamine","volume":"42","author":"Holmes","year":"1992","journal-title":"Mol. Pharm."},{"key":"2024103110233371900_cit9","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/clinchem\/31.11.1795","article-title":"Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias","volume":"31","author":"Iles","year":"1985","journal-title":"Clin. Chem."},{"key":"2024103110233371900_cit10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/diab.30.2.106","article-title":"Prevention of diabetic nephropathy by diet control in the db\/db mouse","volume":"30","author":"Lee","year":"1981","journal-title":"Diabetes"},{"key":"2024103110233371900_cit11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01212231","article-title":"Studies in the diabetic mutant mouse I. Light microscopy and radioautography of pancreatic islets","volume":"6","author":"Like","year":"1970","journal-title":"Diabetologia"},{"key":"2024103110233371900_cit12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0079-6565(89)80008-1","article-title":"High resolution proton magnetic resonance spectroscopy of biological fluids","volume":"21","author":"Nicholson","year":"1989","journal-title":"Progress in NMR Spectroscopy"},{"key":"2024103110233371900_cit13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/bj2110605","article-title":"High resolution 1H NMR studies of vertebrate blood and plasma","volume":"211","author":"Nicholson","year":"1983","journal-title":"Biochem. J."},{"key":"2024103110233371900_cit14","volume-title":"Aldrich Library of 1H and 13C FT-NMR spectra","author":"Pouchert","year":"1993","edition":"2nd edn"},{"key":"2024103110233371900_cit15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2024103110233371900_cit16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/dmr.5610080302","article-title":"Animal models of non-insulin dependent diabetes","volume":"8","author":"Shafrir","year":"1992","journal-title":"Diabetes Metab. Rev."},{"issue":"Suppl. 1","key":"2024103110233371900_cit17","first-page":"A184","article-title":"BRL 49653 normalises glycaemic control in Zucker fa\/fa rats by improving hepatic and peripheral tissue sensitivity to insulin","volume":"36","author":"Smith","year":"1993","journal-title":"Diabetologia"},{"key":"2024103110233371900_cit18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diab.44.9.1087","article-title":"Repeat treatment of obese mice with BRL 49653, a novel and potent insulin sensitiser, enhances insulin action in white adipocytes: association with increased insulin binding and cell surface glucose transporter, (GLUT 4), as measured by photoaffinity labelling","volume":"44","author":"Young","year":"1995","journal-title":"Diabetes"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-7158.1997.tb06808.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/49\/3\/336\/60267682\/j.2042-7158.1997.tb06808.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/49\/3\/336\/60267682\/j.2042-7158.1997.tb06808.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:28:49Z","timestamp":1741138129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/49\/3\/336\/6152953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3,1]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1997,3,1]]},"published-print":{"date-parts":[[1997,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06808.x","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[1997,3]]},"published":{"date-parts":[[1997,3,1]]}}}